DGAT1 ASO treatment reduces hepatic fibrosis without improving hepatic steatosis in DB/DB mice fed methionine choline deficient diets
Publication
, Conference
Yamaguchi, K; Yang, L; McCall, S; Huang, J; Yu, XX; Pandey, SK; Bhanot, S; Monia, BP; Li, Y-X; Diehl, AM
Published in: HEPATOLOGY
October 1, 2006
Duke Scholars
Published In
HEPATOLOGY
ISSN
0270-9139
Publication Date
October 1, 2006
Volume
44
Issue
4
Start / End Page
663A / 663A
Location
Boston, MA
Publisher
JOHN WILEY & SONS INC
Conference Name
57th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases
Related Subject Headings
- Gastroenterology & Hepatology
- 3204 Immunology
- 3202 Clinical sciences
- 1107 Immunology
- 1103 Clinical Sciences
- 1101 Medical Biochemistry and Metabolomics
Citation
APA
Chicago
ICMJE
MLA
NLM
Yamaguchi, K., Yang, L., McCall, S., Huang, J., Yu, X. X., Pandey, S. K., … Diehl, A. M. (2006). DGAT1 ASO treatment reduces hepatic fibrosis without improving hepatic steatosis in DB/DB mice fed methionine choline deficient diets. In HEPATOLOGY (Vol. 44, pp. 663A-663A). Boston, MA: JOHN WILEY & SONS INC.
Yamaguchi, Kanji, Liu Yang, Shannon McCall, Jiawen Huang, Xing Xian Yu, Sanjay K. Pandey, Sanjay Bhanot, Brett P. Monia, Yin-Xiong Li, and Anna Mae Diehl. “DGAT1 ASO treatment reduces hepatic fibrosis without improving hepatic steatosis in DB/DB mice fed methionine choline deficient diets.” In HEPATOLOGY, 44:663A-663A. JOHN WILEY & SONS INC, 2006.
Yamaguchi K, Yang L, McCall S, Huang J, Yu XX, Pandey SK, et al. DGAT1 ASO treatment reduces hepatic fibrosis without improving hepatic steatosis in DB/DB mice fed methionine choline deficient diets. In: HEPATOLOGY. JOHN WILEY & SONS INC; 2006. p. 663A-663A.
Yamaguchi, Kanji, et al. “DGAT1 ASO treatment reduces hepatic fibrosis without improving hepatic steatosis in DB/DB mice fed methionine choline deficient diets.” HEPATOLOGY, vol. 44, no. 4, JOHN WILEY & SONS INC, 2006, pp. 663A-663A.
Yamaguchi K, Yang L, McCall S, Huang J, Yu XX, Pandey SK, Bhanot S, Monia BP, Li Y-X, Diehl AM. DGAT1 ASO treatment reduces hepatic fibrosis without improving hepatic steatosis in DB/DB mice fed methionine choline deficient diets. HEPATOLOGY. JOHN WILEY & SONS INC; 2006. p. 663A-663A.
Published In
HEPATOLOGY
ISSN
0270-9139
Publication Date
October 1, 2006
Volume
44
Issue
4
Start / End Page
663A / 663A
Location
Boston, MA
Publisher
JOHN WILEY & SONS INC
Conference Name
57th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases
Related Subject Headings
- Gastroenterology & Hepatology
- 3204 Immunology
- 3202 Clinical sciences
- 1107 Immunology
- 1103 Clinical Sciences
- 1101 Medical Biochemistry and Metabolomics